Search - tctmd.com

Displaying 41 - 60 of 501

Sort: Relevancy | Date

Presentation TCT 2024

Case Presentation: CTO in a Patient with LV Dysfunction and Last Remaining Conduit

Presenter: Kais Hyasat

October 29, 2024

Presentation TCT 2024

Case Resolution: CTO in a Patient with LV Dysfunction Donor Vessel Last Remaining Conduit

Presenter: Kais Hyasat

October 29, 2024

News Conference News TCT 2024

New DanGer Shock Data: Hemodynamics, Renal Dysfunction, and Bleeding

Caitlin E. Cox

October 28, 2024

Presentation TCT 2024

TCT 582: Evaluation of LVEDP Change During High-Risk PCI With and Without Impella Support (ELVIS): A Pilot Trial

Presenter: Juergen Leick

October 28, 2024

News Conference News EACTS 2024

‘Teleprehabilitation’ Before Cardiac Surgery Improves the Outcomes That Follow

Yael L. Maxwell

October 17, 2024

News Daily News

Small Fraction of STEMI Patients With Shock Meet DanGer Criteria

Caitlin E. Cox

October 11, 2024

News Conference News EACTS 2024

Will Semaglutide Change Cardiac Surgery? It Already Has

Yael L. Maxwell

October 10, 2024

News Conference News HFSA 2024

Biomarker and Echo Data Bolster Vutrisiran’s Promise in ATTR-CM

L.A. McKeown

October 04, 2024

News Conference News ESC 2024

ESC’s 2024 CCS Guidelines Embrace New Data, Smooth Old Tensions

Michael O'Riordan

September 17, 2024

News Conference News ESC 2024

ABYSS: Safety Signal Seen When Beta-blockers Stopped in Post-MI Patients

Michael O'Riordan

August 30, 2024

News Daily News

Sudden Deaths After Acute MI Have Dropped, but Early Weeks Remain Risky

Yael L. Maxwell

August 08, 2024

News Daily News

CMR Could Change Diagnosis, Management of Suspected NSTEMI: OxAMI

Yael L. Maxwell

July 18, 2024

News Daily News

RECOVER IV Impella Trial Halted in the Wake of DanGer Shock

Caitlin E. Cox

June 18, 2024

News Industry News

CellProthera announces positive Phase I/IIb data for ProtheraCytes® cell therapy in acute myocardial infarction

May 29, 2024

News Daily News

TAVI Outcomes Linked to LV Recovery in Patients With Severe Dysfunction

Michael O'Riordan

May 06, 2024

News Conference News SCAI 2024

AI Picks Up on Info Operators Miss on Angiograms: AI-ENCODE

L.A. McKeown

May 03, 2024

News Conference News EHRA 2024

Preventive VT Ablation Before ICD Helps High-risk Ischemic Cardiomyopathy Patients

Todd Neale

April 10, 2024

News Daily News

Abiomed Recalls Labeling for Left-Sided Impella Pumps: FDA

Caitlin E. Cox

March 21, 2024

News Conference News CRT 2024

SAFE-MCS: Monitoring System Intercepts Bleeding in High-risk PCI

L.A. McKeown

March 15, 2024

Presentation THT Abstracts 2024

A Report from the Cardiogenic Shock Working Group on use of Impella 5.0/5.5 for Cardiogenic Shock and Successful Bridge to Recovery, durable LVAD or Heart Transplantation

Presenter: Maryjane Farr

March 05, 2024

Advertisement

Case Presentation: CTO in a Patient with LV Dysfunction and Last Remaining Conduit

Case Resolution: CTO in a Patient with LV Dysfunction Donor Vessel Last Remaining Conduit

New DanGer Shock Data: Hemodynamics, Renal Dysfunction, and Bleeding

TCT 582: Evaluation of LVEDP Change During High-Risk PCI With and Without Impella Support (ELVIS): A Pilot Trial

‘Teleprehabilitation’ Before Cardiac Surgery Improves the Outcomes That Follow

Small Fraction of STEMI Patients With Shock Meet DanGer Criteria

Will Semaglutide Change Cardiac Surgery? It Already Has

Biomarker and Echo Data Bolster Vutrisiran’s Promise in ATTR-CM

ESC’s 2024 CCS Guidelines Embrace New Data, Smooth Old Tensions

ABYSS: Safety Signal Seen When Beta-blockers Stopped in Post-MI Patients

Sudden Deaths After Acute MI Have Dropped, but Early Weeks Remain Risky

CMR Could Change Diagnosis, Management of Suspected NSTEMI: OxAMI

RECOVER IV Impella Trial Halted in the Wake of DanGer Shock

CellProthera announces positive Phase I/IIb data for ProtheraCytes® cell therapy in acute myocardial infarction

TAVI Outcomes Linked to LV Recovery in Patients With Severe Dysfunction

AI Picks Up on Info Operators Miss on Angiograms: AI-ENCODE

Preventive VT Ablation Before ICD Helps High-risk Ischemic Cardiomyopathy Patients

Abiomed Recalls Labeling for Left-Sided Impella Pumps: FDA

SAFE-MCS: Monitoring System Intercepts Bleeding in High-risk PCI

A Report from the Cardiogenic Shock Working Group on use of Impella 5.0/5.5 for Cardiogenic Shock and Successful Bridge to Recovery, durable LVAD or Heart Transplantation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content